Will Diagnostic Cardiology Vendors Look To Product Innovation?

Ruzanna Harutyunyan's picture

The Healthcare group at Frost & Sullivan is pleased to announce that it will be hosting an interactive analyst briefing on the European Diagnostic Cardiology Markets on 11 December 2008 at 3pm GMT.

With most diagnostic cardiology market segments nearing saturation, vendors in Europe are faced with an immense challenge of keeping profit margins at acceptable levels. As the global economic slowdown begins to affect hospital purchasing power, vendors are also left with few resources to invest in research and development.


This may force vendors into strategising new product innovations to sustain market growth. However, certain developments in the cardiac CT and diagnostic ECG markets do suggest that the industry is not overlooking the need for new product development.

"Despite an increase in the number of procedures related to cardiovascular diseases, the reimbursement scenario for diagnostic cardiology hasn't improved significantly," notes Frost & Sullivan Research Analyst Krishanu Bhattacharjee. 'However the R&D plans of certain vendors in selected market segments, such as cardiac CT and ECG, indicate that the industry is concurrently preparing for a major change in the market dynamics."

Highlights of this will briefing include analyses of the trends in procedure numbers, diagnostic cardiology market sizing, current and future technology trends, immediate growth opportunities and growth rate projections.

The discussion will benefit original equipment manufacturers, developers and distributors of diagnostic ECG, stress test devices, ECG data management systems, cardiac CT, cardiovascular MR, echocardiography and interventional cardiology by discussing emerging trends and providing forward projections and recommendations for the European diagnostic cardiology market.